Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey data, 1997-2002

Clinical Therapeutics
Robert J MorlockDavid Y Mitchell

Abstract

The aims of this work were to characterize ambulatory patients in the United States presenting with primary or secondary insomnia complaints and resultant diagnoses, and to describe the characteristics of patients treated with medications commonly used for sleep complaints. Data from the National Ambulatory Medical Care Survey for the years 1997 through 2002 were analyzed. Data were stratified by patient characteristics, physician specialty, resulting diagnosis, and medications prescribed or provided. The unit of analysis was the individual patient visit; statistical comparisons were made using the chi(2) test for categorical variables and the Rao-Scott design-adjusted chi(2) test for comparisons of patient age groups. P<0.05 was the criterion for statistical significance. Cells containing < 30 observations were not included in the statistical analysis. The data included 147,945 patient visit records; rates of physician response to the survey ranged from 62.9% in 1999 to 70.4% in 2002. Based on this sample, it was projected that 30 million office visits involved insomnia complaints over the 6-year period from 1997 to 2002 throughout the United States. With a total of 4.9 billion physician visits projected for that time period, ...Continue Reading

References

Nov 1, 1993·Archives of Family Medicine·S E Radecki, S A Brunton
Oct 27, 1997·The American Journal of Psychiatry·G E Simon, M VonKorff
Aug 15, 2002·Academic Medicine : Journal of the Association of American Medical Colleges·Larry A Green, George E Fryer
Dec 17, 2002·Journal of Psychiatric Research·Maurice M Ohayon, Thomas Roth
Jan 18, 2003·Sleep Medicine Reviews·Maurice M Ohayon
Feb 21, 2004·Journal of the American College of Cardiology·Hans K Meier-EwertJanet M Mullington
Apr 6, 2004·Sleep Medicine Reviews·Susan A MartinRonald D Chervin
Apr 17, 2004·The Medical Clinics of North America·Michael J Sateia, Wilfred R Pigeon
Sep 29, 2004·Diabetes Care·Peter M NilssonGöran Berglund
Nov 17, 2004·Clinical Cornerstone·Timothy Roehrs, Thomas Roth
Jan 12, 2005·Archives of Internal Medicine·Maurice M Ohayon
Jan 25, 2005·Current Diabetes Reports·Anna SvatikovaVirend K Somers
Mar 10, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ram B SinghPankaj Gupta
Jul 5, 2005·The Journal of the American Board of Family Practice·James E Aikens, Mary E Rouse

Citations

Feb 14, 2013·Behavioral Sleep Medicine·Janet M Y CheungBandana Saini
Sep 10, 2011·Drug, Healthcare and Patient Safety·L Leanne LaiYen Chi Lai
Sep 28, 2012·American Journal of Veterinary Research·Mario GiorgiAngela Briganti
Sep 21, 2013·Indian Journal of Psychological Medicine·Gurvinder Pal Singh, Neeraj Loona
Aug 2, 2014·Psychiatry Research·Stephanie C LicataScott E Lukas
Feb 7, 2009·Current Medical Research and Opinion·Rajesh BalkrishnanMark J Cziraky
Jun 3, 2010·Current Medical Research and Opinion·Carl V AscheChristopher L Drake
Oct 4, 2008·European Journal of Pharmacology·Stephanie C LicataScott E Lukas
Feb 26, 2008·Pharmacology, Biochemistry, and Behavior·Stephanie C Licata, James K Rowlett
Jan 15, 2010·Pharmacoepidemiology and Drug Safety·Samantha A Hollingworth, Dan J Siskind
Jul 21, 2012·Drug Metabolism and Pharmacokinetics·Chia-Hsien ChangLi-Jen Lin
Nov 30, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Julieta ScaloKaren Rascati
Oct 4, 2011·Biological Psychiatry·Goeran HajakRonald C Kessler
Feb 15, 2011·Sleep Medicine·Megan E RuiterKenneth L Lichstein
Feb 6, 2014·Sleep·Suzanne M BertischCatherine Buettner
May 5, 2017·Journal of the American Geriatrics Society·Andrew M NamenEdward F Haponik
Feb 26, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Hazel EverittPaul Little
Nov 16, 2007·Journal of Clinical Psychopharmacology·Sanne de HaasJoop van Gerven
Jan 28, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Renee GarrickBeth Stefanchik
Jun 1, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Erik K FrommeMichelle Hribar
Sep 14, 2007·International Journal of Palliative Nursing·Addy Hackett, Alfredo Gaitan
Jun 18, 2009·Current Medical Research and Opinion·Michael PollackMark J Cziraky
Jan 11, 2011·Diabetes/metabolism Research and Reviews·R R SimonJ W Anderson
Jun 23, 2011·The Annals of Pharmacotherapy·Stephanie V TachéDarren M Ashcroft
Aug 12, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Alexandros N VgontzasEdward O Bixler
Apr 12, 2017·American Journal of Respiratory and Critical Care Medicine·Amy S JordanJohn Trinder
May 16, 2018·The Cochrane Database of Systematic Reviews·Hazel EverittSue Wilson

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.